首页 > 最新文献

Oman Journal of Ophthalmology最新文献

英文 中文
A retrospective study of the incidence, patterns, and risk factors of retinopathy of prematurity in infants with birth weight >1500 g in a South Indian tertiary care hospital. 对南印度一家三级医院出生体重为b> 1500 g的早产儿视网膜病变的发生率、模式和危险因素的回顾性研究
Q3 Medicine Pub Date : 2024-10-24 eCollection Date: 2024-09-01 DOI: 10.4103/ojo.ojo_35_24
Vishalakshi Bhat, Shankargouda H Patil

Objective: The objective of the study was to determine the incidence, patterns, and risk factors for the development of retinopathy of prematurity (ROP) in infants weighing >1500 g at birth.

Materials and methods: A retrospective analysis was done of the ROP screening records between April 2019 and March 2022. All the infants with birth weight >1500 g who underwent ROP screening were included. Data collected included demographic details, details of the risk factors (respiratory distress syndrome [RDS], hypoxia, anemia, septicemia, patent ductus arteriosus, congenital heart disease [CHD], i.e., atrial septal defects or ventricular septal defects, and multiple gestations), and ocular examination findings. Statistical analyses included calculation of mean, range, Chi-square test, and bivariate logistic regression for associations of risk factors with ROP.

Results: ROP was noted in 16.6% of the 336 eyes of 168 infants. The mean birth weight and mean gestational age (GA) of the infants were 1850 ± 33 g and 33.33 weeks ± 1.71 weeks, respectively. Eighteen eyes (32.1%) had Stage I, 17 eyes (30.35%) had Stage II, and 11 eyes (19.64%) had Stage III ROP in Zone II. Aggressive ROP was seen in 8 eyes (14.28%) and stage 5 ROP in two eyes (0.59%). Male gender, GA, CHD, and RDS showed a statistically significant association with the development of ROP in these infants.

Conclusion: ROP was seen in 16.66% of our subjects. Treatment was required in 6.25% of infants. Risk factors for the development of ROP were low gestational age, male gender, the presence of RDS, and congenital heart disease.

目的:本研究的目的是确定出生时体重为150 ~ 1500 g的婴儿发生早产儿视网膜病变(ROP)的发生率、模式和危险因素。材料和方法:回顾性分析2019年4月至2022年3月的ROP筛选记录。所有接受ROP筛查的出生体重为b> 1500 g的婴儿均被纳入。收集的资料包括人口统计资料、危险因素(呼吸窘迫综合征[RDS]、缺氧、贫血、败血症、动脉导管未闭、先天性心脏病[CHD],即房间隔缺损或室间隔缺损、多胎妊娠)的详细信息以及眼科检查结果。统计分析包括计算均数、极差、卡方检验和双变量logistic回归分析危险因素与ROP的相关性。结果:168例婴幼儿336眼ROP发生率为16.6%。新生儿平均出生体重1850±33 g,平均胎龄(GA) 33.33周±1.71周。II区ROP为I期18眼(32.1%),II期17眼(30.35%),III期11眼(19.64%)。侵袭性ROP 8眼(14.28%),5期ROP 2眼(0.59%)。男性性别、GA、CHD和RDS与这些婴儿ROP的发生有统计学意义。结论:ROP发生率为16.66%。6.25%的婴儿需要治疗。发生ROP的危险因素为低胎龄、男性、存在RDS和先天性心脏病。
{"title":"A retrospective study of the incidence, patterns, and risk factors of retinopathy of prematurity in infants with birth weight >1500 g in a South Indian tertiary care hospital.","authors":"Vishalakshi Bhat, Shankargouda H Patil","doi":"10.4103/ojo.ojo_35_24","DOIUrl":"10.4103/ojo.ojo_35_24","url":null,"abstract":"<p><strong>Objective: </strong>The objective of the study was to determine the incidence, patterns, and risk factors for the development of retinopathy of prematurity (ROP) in infants weighing >1500 g at birth.</p><p><strong>Materials and methods: </strong>A retrospective analysis was done of the ROP screening records between April 2019 and March 2022. All the infants with birth weight >1500 g who underwent ROP screening were included. Data collected included demographic details, details of the risk factors (respiratory distress syndrome [RDS], hypoxia, anemia, septicemia, patent ductus arteriosus, congenital heart disease [CHD], i.e., atrial septal defects or ventricular septal defects, and multiple gestations), and ocular examination findings. Statistical analyses included calculation of mean, range, Chi-square test, and bivariate logistic regression for associations of risk factors with ROP.</p><p><strong>Results: </strong>ROP was noted in 16.6% of the 336 eyes of 168 infants. The mean birth weight and mean gestational age (GA) of the infants were 1850 ± 33 g and 33.33 weeks ± 1.71 weeks, respectively. Eighteen eyes (32.1%) had Stage I, 17 eyes (30.35%) had Stage II, and 11 eyes (19.64%) had Stage III ROP in Zone II. Aggressive ROP was seen in 8 eyes (14.28%) and stage 5 ROP in two eyes (0.59%). Male gender, GA, CHD, and RDS showed a statistically significant association with the development of ROP in these infants.</p><p><strong>Conclusion: </strong>ROP was seen in 16.66% of our subjects. Treatment was required in 6.25% of infants. Risk factors for the development of ROP were low gestational age, male gender, the presence of RDS, and congenital heart disease.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 3","pages":"357-361"},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620298/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142801240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An update of multimodal imaging in white dot syndrome. 白点综合征多模态影像学研究进展。
Q3 Medicine Pub Date : 2024-10-24 eCollection Date: 2024-09-01 DOI: 10.4103/ojo.ojo_116_24
Ahana Sen, Chetan Rao, Jyotirmay Biswas

The white dot syndromes are a group of phenotypically similar disorders characterized by multiple lesions at the level of the outer retina, retinal pigment epithelium, and choroid. Common white dot syndromes whose imaging modalities have been described in this article are multiple evanescent white dot syndrome, acute posterior multifocal placoid pigment epitheliopathy, acute zonal occult outer retinopathy, multifocal choroiditis and panuveitis, punctate inner choroidopathy, serpiginous choroiditis, and birdshot chorioretinopathy. The various imaging modalities help us to better understand the pathophysiology of the various entities and help in diagnosing, monitoring, and prognosticating them. Optical coherence tomography angiography (OCTA) is a comparatively newer tool that helps us to visualize lesions in the choroid that correlate with indocyanine green angiography (ICGA) findings. Even though it is of limited value and cannot replace ICGA, it had gained considerable interest among ophthalmologists. Similarly, the noninvasive nature of modalities such as fundus autofluorescence and OCT makes them appealing and preferable over invasive techniques such as fundus fluorescein angiography and ICGA.

白点综合征是一组表型相似的疾病,其特征是外视网膜、视网膜色素上皮和脉络膜水平的多发性病变。本文所描述的常见白点综合征的影像学表现有多发性消失性白点综合征、急性后多发灶类胎盘色素上皮病、急性带状隐匿性外视网膜病变、多灶性脉络膜炎和全葡萄膜炎、点状内脉络膜病、蛇形脉络膜炎和鸟状脉络膜视网膜病。各种成像方式帮助我们更好地了解各种实体的病理生理学,并帮助诊断、监测和预测它们。光学相干断层血管造影(OCTA)是一种相对较新的工具,可以帮助我们可视化与吲哚菁绿血管造影(ICGA)结果相关的脉络膜病变。尽管它的价值有限,不能取代ICGA,但它已经引起了眼科医生的相当大的兴趣。类似地,眼底自身荧光和OCT等非侵入性技术使它们比眼底荧光素血管造影和ICGA等侵入性技术更有吸引力和可取。
{"title":"An update of multimodal imaging in white dot syndrome.","authors":"Ahana Sen, Chetan Rao, Jyotirmay Biswas","doi":"10.4103/ojo.ojo_116_24","DOIUrl":"10.4103/ojo.ojo_116_24","url":null,"abstract":"<p><p>The white dot syndromes are a group of phenotypically similar disorders characterized by multiple lesions at the level of the outer retina, retinal pigment epithelium, and choroid. Common white dot syndromes whose imaging modalities have been described in this article are multiple evanescent white dot syndrome, acute posterior multifocal placoid pigment epitheliopathy, acute zonal occult outer retinopathy, multifocal choroiditis and panuveitis, punctate inner choroidopathy, serpiginous choroiditis, and birdshot chorioretinopathy. The various imaging modalities help us to better understand the pathophysiology of the various entities and help in diagnosing, monitoring, and prognosticating them. Optical coherence tomography angiography (OCTA) is a comparatively newer tool that helps us to visualize lesions in the choroid that correlate with indocyanine green angiography (ICGA) findings. Even though it is of limited value and cannot replace ICGA, it had gained considerable interest among ophthalmologists. Similarly, the noninvasive nature of modalities such as fundus autofluorescence and OCT makes them appealing and preferable over invasive techniques such as fundus fluorescein angiography and ICGA.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 3","pages":"325-333"},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620295/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142801254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral cyclophosphamide treatment for clinical periocular inflammation of unknown origin. 口服环磷酰胺治疗不明原因的临床眼周炎症。
Q3 Medicine Pub Date : 2024-10-24 eCollection Date: 2024-09-01 DOI: 10.4103/ojo.ojo_30_24
Arash Maleki, Stephen D Anesi, Peter Y Chang, C Stephen Foster

This study outlines a scenario involving unilateral periocular inflammation exhibited resistance to conventional immunomodulatory therapy (IMT) and biologic response modifying agents, which was successfully managed with oral cyclophosphamide monotherapy. A 39-year-old male visited our clinic, expressing discomfort and swelling in his left upper eyelid for six months. All multidisciplinary consultations and imaging yielded normal results. He remained consistently on a dosage of 50 mg oral prednisone. Blood tests yielded results within the normal range or were negative, with the exception of the antinuclear antibody. He did not respond to conventional IMT and biological response modifier agents. Ultimately, the patient began oral cyclophosphamide. One month after commencing cyclophosphamide treatment, the oral prednisone dosage was gradually reduced without any flare-up. oral cyclophosphamide can serve as a valuable treatment for periocular inflammation that does not respond to standard conventional IMT and biologic response modifier agents.

本研究概述了单侧眼周炎症表现出对常规免疫调节治疗(IMT)和生物反应修饰剂的抵抗,并成功地通过口服环磷酰胺单药治疗。一名39岁男性前来就诊,表现左上眼睑不适、肿胀半年。所有多学科会诊和影像学检查结果均正常。他一直服用50毫克的口服强的松。血液检查结果在正常范围内或阴性,抗核抗体除外。他对常规IMT和生物反应调节剂没有反应。最终,患者开始口服环磷酰胺。开始环磷酰胺治疗1个月后,口服强的松剂量逐渐减少,无任何急性发作。口服环磷酰胺可作为对标准常规IMT和生物反应调节剂无效的眼周炎症的有价值的治疗方法。
{"title":"Oral cyclophosphamide treatment for clinical periocular inflammation of unknown origin.","authors":"Arash Maleki, Stephen D Anesi, Peter Y Chang, C Stephen Foster","doi":"10.4103/ojo.ojo_30_24","DOIUrl":"10.4103/ojo.ojo_30_24","url":null,"abstract":"<p><p>This study outlines a scenario involving unilateral periocular inflammation exhibited resistance to conventional immunomodulatory therapy (IMT) and biologic response modifying agents, which was successfully managed with oral cyclophosphamide monotherapy. A 39-year-old male visited our clinic, expressing discomfort and swelling in his left upper eyelid for six months. All multidisciplinary consultations and imaging yielded normal results. He remained consistently on a dosage of 50 mg oral prednisone. Blood tests yielded results within the normal range or were negative, with the exception of the antinuclear antibody. He did not respond to conventional IMT and biological response modifier agents. Ultimately, the patient began oral cyclophosphamide. One month after commencing cyclophosphamide treatment, the oral prednisone dosage was gradually reduced without any flare-up. oral cyclophosphamide can serve as a valuable treatment for periocular inflammation that does not respond to standard conventional IMT and biologic response modifier agents.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 3","pages":"399-402"},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620296/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142801906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anterior segment ischemia following scleral buckle surgery: The forgotten enemy. 巩膜扣手术后前段缺血:被遗忘的敌人。
Q3 Medicine Pub Date : 2024-10-24 eCollection Date: 2024-09-01 DOI: 10.4103/ojo.ojo_34_24
Janani Sreenivasan, Aditi Joshi, Aashul Chawla

Anterior segment ischemia (ASI) is a rare, almost forgotten complication of scleral buckle (SB) surgery. The course varies from mild self-limited to severe type causing significant vision loss. A number of local and systemic factors can precipitate ASI. It is important to be aware of these factors and take the necessary steps to avoid this complication. Despite that, if the patient develops ASI, early recognition is important. Mild cases are managed conservatively whereas severe cases will require removal of the band. We present a case of an 18-year-old male who developed a mild type of ASI post-SB surgery managed conservatively.

前段缺血(ASI)是一种罕见的、几乎被遗忘的巩膜扣(SB)手术并发症。病程从轻度自限性到严重导致严重视力丧失不等。许多局部和系统性因素都可能导致ASI。重要的是要意识到这些因素,并采取必要的措施来避免这种并发症。尽管如此,如果患者发展为ASI,早期识别是很重要的。轻微的病例保守处理,而严重的病例将需要移除绷带。我们报告了一例18岁的男性,他在sb手术后发展为轻度ASI,保守处理。
{"title":"Anterior segment ischemia following scleral buckle surgery: The forgotten enemy.","authors":"Janani Sreenivasan, Aditi Joshi, Aashul Chawla","doi":"10.4103/ojo.ojo_34_24","DOIUrl":"10.4103/ojo.ojo_34_24","url":null,"abstract":"<p><p>Anterior segment ischemia (ASI) is a rare, almost forgotten complication of scleral buckle (SB) surgery. The course varies from mild self-limited to severe type causing significant vision loss. A number of local and systemic factors can precipitate ASI. It is important to be aware of these factors and take the necessary steps to avoid this complication. Despite that, if the patient develops ASI, early recognition is important. Mild cases are managed conservatively whereas severe cases will require removal of the band. We present a case of an 18-year-old male who developed a mild type of ASI post-SB surgery managed conservatively.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 3","pages":"396-398"},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620293/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142801257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microbial keratitis at a single tertiary eye care in Andhra Pradesh: A 12-year analysis of microbiological profile and in vitro susceptibility of bacterial isolates. 安得拉邦单一三级眼科护理的微生物角膜炎:微生物谱和细菌分离物体外敏感性的12年分析。
Q3 Medicine Pub Date : 2024-10-24 eCollection Date: 2024-09-01 DOI: 10.4103/ojo.ojo_18_24
Bhagyasree Madduri, Nitin Mohan, Merle Fernandez, Joveeta Joseph

Context: Microbial keratitis is a potentially vision-threatening emergency that demands prompt diagnosis and treatment to ensure better vision recovery. Empirical use of broad-spectrum antimicrobial therapies is often the primary treatment modality, which is then tailored according to clinical response, cultured organisms, and their sensitivities. Since the spectrum of microbial agents associated with corneal ulcers is wide and varies from one geographical location to another, it is imperative that local microbial trends and susceptibility patterns are analyzed to enable better care in the management of these patients.

Aims: The aim of the study was to report the microbiological profile and in vitro drug susceptibility patterns of bacterial isolates obtained from patients with microbial keratitis in a single tertiary center in Andhra Pradesh over 12 years.

Methods: Microbiology records of culture-positive microbial keratitis that underwent a diagnostic corneal scraping and cultures from the years 2010 to 2021 were reviewed. Trends in bacterial and fungal etiology along with the antibiotic susceptibility profile of bacteria were analyzed.

Statistical analysis used: Frequency distribution was obtained, and percentages were calculated.

Results: Of the 8529 microbial keratitis samples, 3581 corneal scrapings were culture positive which included Gram-positive bacteria (1054/3581, 29.4%), Gram-negative bacteria (476/3581, 13.2%), fungi (2051/3581, 57.2%), and parasites (369/3581, 10.3%). The most common fungal isolate was Fusarium species (557/1748, 31.8%) followed by Aspergillus flavus (495/1748, 28.3%). Similarly, the most common Gram-positive bacteria included Streptococcus pneumoniae (297/891, 33.3%) and Staphylococcus species (213/891, 23.9%), and the most common Gram-negative bacteria was Pseudomonas aeruginosa (294/403, 72.9%). Overall susceptibility patterns showed that Gram-positive bacteria were susceptible to vancomycin (92%), cefazolin (88%), and chloramphenicol (86%), while Gram-negative bacteria were most susceptible to gentamicin and amikacin (81%). The susceptibility to amikacin and gentamicin increased significantly from 71% in 2010 to 92% in 2021 and 74% in 2010 to 92% in 2021, respectively. In comparison, the susceptibility of fluoroquinolones for both Gram-positive and Gram-negative bacteria did not show any significant change over the study period.

Conclusions: The prevalence of fungal and bacterial keratitis has remained unchanged over the years. This study reinforced that fluoroquinolones and vancomycin continue to be good empiric therapies for treating bacterial keratitis in Andhra Pradesh.

背景:微生物角膜炎是一种潜在的威胁视力的紧急情况,需要及时诊断和治疗,以确保更好的视力恢复。广谱抗菌药物的经验性使用通常是主要的治疗方式,然后根据临床反应、培养的生物体及其敏感性进行调整。由于与角膜溃疡相关的微生物制剂的光谱很广,并且因地理位置而异,因此必须分析当地微生物趋势和敏感性模式,以便在这些患者的管理中提供更好的护理。目的:该研究的目的是报告在安得拉邦的一个三级中心获得的细菌性角膜炎患者的微生物学特征和体外药物敏感性模式,超过12年。方法:回顾2010年至2021年进行诊断性角膜刮痧和培养的培养阳性微生物性角膜炎的微生物学记录。分析了细菌和真菌病因学趋势以及细菌的抗生素敏感性。采用统计分析:得到频率分布,计算百分比。结果:8529份微生物性角膜炎标本中,培养阳性3581份,其中革兰氏阳性菌(1054/3581,29.4%)、革兰氏阴性菌(476/3581,13.2%)、真菌(2051/3581,57.2%)、寄生虫(369/3581,10.3%)。最常见的真菌分离物为镰刀菌(557/1748,31.8%),其次为黄曲霉(495/1748,28.3%)。最常见的革兰氏阳性菌为肺炎链球菌(297/891,33.3%)和葡萄球菌(213/891,23.9%),最常见的革兰氏阴性菌为铜绿假单胞菌(294/403,72.9%)。总体药敏模式显示,革兰氏阳性菌对万古霉素(92%)、头孢唑林(88%)和氯霉素(86%)最敏感,革兰氏阴性菌对庆大霉素和阿米卡星(81%)最敏感。对阿米卡星和庆大霉素的敏感性分别从2010年的71%和74%显著增加到2021年的92%。相比之下,氟喹诺酮类药物对革兰氏阳性和革兰氏阴性细菌的敏感性在研究期间没有显示出任何显著变化。结论:真菌性和细菌性角膜炎的患病率多年来保持不变。这项研究强调,氟喹诺酮类药物和万古霉素仍然是治疗安得拉邦细菌性角膜炎的良好经验性疗法。
{"title":"Microbial keratitis at a single tertiary eye care in Andhra Pradesh: A 12-year analysis of microbiological profile and <i>in vitro</i> susceptibility of bacterial isolates.","authors":"Bhagyasree Madduri, Nitin Mohan, Merle Fernandez, Joveeta Joseph","doi":"10.4103/ojo.ojo_18_24","DOIUrl":"10.4103/ojo.ojo_18_24","url":null,"abstract":"<p><strong>Context: </strong>Microbial keratitis is a potentially vision-threatening emergency that demands prompt diagnosis and treatment to ensure better vision recovery. Empirical use of broad-spectrum antimicrobial therapies is often the primary treatment modality, which is then tailored according to clinical response, cultured organisms, and their sensitivities. Since the spectrum of microbial agents associated with corneal ulcers is wide and varies from one geographical location to another, it is imperative that local microbial trends and susceptibility patterns are analyzed to enable better care in the management of these patients.</p><p><strong>Aims: </strong>The aim of the study was to report the microbiological profile and <i>in vitro</i> drug susceptibility patterns of bacterial isolates obtained from patients with microbial keratitis in a single tertiary center in Andhra Pradesh over 12 years.</p><p><strong>Methods: </strong>Microbiology records of culture-positive microbial keratitis that underwent a diagnostic corneal scraping and cultures from the years 2010 to 2021 were reviewed. Trends in bacterial and fungal etiology along with the antibiotic susceptibility profile of bacteria were analyzed.</p><p><strong>Statistical analysis used: </strong>Frequency distribution was obtained, and percentages were calculated.</p><p><strong>Results: </strong>Of the 8529 microbial keratitis samples, 3581 corneal scrapings were culture positive which included Gram-positive bacteria (1054/3581, 29.4%), Gram-negative bacteria (476/3581, 13.2%), fungi (2051/3581, 57.2%), and parasites (369/3581, 10.3%). The most common fungal isolate was <i>Fusarium</i> species (557/1748, 31.8%) followed by <i>Aspergillus flavus</i> (495/1748, 28.3%). Similarly, the most common Gram-positive bacteria included <i>Streptococcus pneumoniae</i> (297/891, 33.3%) and <i>Staphylococcus</i> species (213/891, 23.9%), and the most common Gram-negative bacteria was <i>Pseudomonas aeruginosa</i> (294/403, 72.9%). Overall susceptibility patterns showed that Gram-positive bacteria were susceptible to vancomycin (92%), cefazolin (88%), and chloramphenicol (86%), while Gram-negative bacteria were most susceptible to gentamicin and amikacin (81%). The susceptibility to amikacin and gentamicin increased significantly from 71% in 2010 to 92% in 2021 and 74% in 2010 to 92% in 2021, respectively. In comparison, the susceptibility of fluoroquinolones for both Gram-positive and Gram-negative bacteria did not show any significant change over the study period.</p><p><strong>Conclusions: </strong>The prevalence of fungal and bacterial keratitis has remained unchanged over the years. This study reinforced that fluoroquinolones and vancomycin continue to be good empiric therapies for treating bacterial keratitis in Andhra Pradesh.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 3","pages":"352-356"},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620300/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142801903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Choroidal metastasis as the initial manifestation of lung carcinoma. 脉络膜转移是肺癌的初始表现。
Q3 Medicine Pub Date : 2024-10-24 eCollection Date: 2024-09-01 DOI: 10.4103/ojo.ojo_157_23
Ahana Sen, Kalpita Das, Md Shahid Alam
{"title":"Choroidal metastasis as the initial manifestation of lung carcinoma.","authors":"Ahana Sen, Kalpita Das, Md Shahid Alam","doi":"10.4103/ojo.ojo_157_23","DOIUrl":"10.4103/ojo.ojo_157_23","url":null,"abstract":"","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 3","pages":"403-404"},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620294/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142801598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carotid-cavernous fistula due to contralateral orbital trauma. 对侧眶外伤所致颈海绵状瘘。
Q3 Medicine Pub Date : 2024-10-24 eCollection Date: 2024-09-01 DOI: 10.4103/ojo.ojo_258_23
V G Namitha, R Neena, E R Jayadevan

Direct carotid cavernous fistula is an abnormal arterio-venous connection from the carotid artery to the cavernous sinus (CS), resulting in high-pressure arterial blood entering the low-pressure venous CS. Most often, it occurs posttrauma and presents with ipsilateral orbital signs. In this report, we describe the case of a 54-year-old man, who presented with a late-onset right-sided red eye and diplopia following contralateral (left sided) orbital trauma (road traffic accident 7 months ago). Ocular examination revealed signs of Lateral rectus palsy, axial proptosis, and elevated intraocular pressure with dilated episcleral vessels in the right eye. Clinical findings were consistent with the diagnosis of right-sided direct CCF. To our surprise, digital subtraction angiogram revealed a left CCF with prominence of signs on the contralateral side. He underwent near-total endovascular coiling of the fistula, with initial aggravation of symptoms followed by near-total resolution.

颈动脉海绵窦直接瘘是颈动脉与海绵窦(CS)的动静脉连接异常,导致高压动脉血进入低压静脉CS。大多数情况下,它发生在创伤后,并表现为同侧眼眶征象。在本报告中,我们描述了一个54岁的男性病例,他在7个月前的道路交通事故中出现对侧(左侧)眶外伤后出现晚发性右侧红眼和复视。眼部检查显示右眼有外侧直肌麻痹、轴突、眼压升高及外膜血管扩张的征象。临床表现与右侧直接CCF的诊断一致。令我们惊讶的是,数字减影血管造影显示左侧CCF伴对侧显著征象。他接受了几乎完全的血管内瘘管盘绕术,最初症状加重,随后几乎完全缓解。
{"title":"Carotid-cavernous fistula due to contralateral orbital trauma.","authors":"V G Namitha, R Neena, E R Jayadevan","doi":"10.4103/ojo.ojo_258_23","DOIUrl":"10.4103/ojo.ojo_258_23","url":null,"abstract":"<p><p>Direct carotid cavernous fistula is an abnormal arterio-venous connection from the carotid artery to the cavernous sinus (CS), resulting in high-pressure arterial blood entering the low-pressure venous CS. Most often, it occurs posttrauma and presents with ipsilateral orbital signs. In this report, we describe the case of a 54-year-old man, who presented with a late-onset right-sided red eye and diplopia following contralateral (left sided) orbital trauma (road traffic accident 7 months ago). Ocular examination revealed signs of Lateral rectus palsy, axial proptosis, and elevated intraocular pressure with dilated episcleral vessels in the right eye. Clinical findings were consistent with the diagnosis of right-sided direct CCF. To our surprise, digital subtraction angiogram revealed a left CCF with prominence of signs on the contralateral side. He underwent near-total endovascular coiling of the fistula, with initial aggravation of symptoms followed by near-total resolution.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 3","pages":"384-387"},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620318/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142801564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of neuro-optometric rehabilitation on adult oculomotor challenges - A systematic review. 神经视光康复对成人动眼肌挑战的影响-系统综述。
Q3 Medicine Pub Date : 2024-10-24 eCollection Date: 2024-09-01 DOI: 10.4103/ojo.ojo_60_24
Judy Jose, Bincy M George, Sulatha V Bhandary, Dushyanth Babu Jasti

Neuro-optometric rehabilitation has a broad range of potential rehabilitative applications in neurological and developmental conditions affecting the eye. There is a dearth of evidence supporting its effectiveness, especially in adults. To address this issue, we systematically reviewed literature published in English between January 2000 and June 2022, obtained from search engines such as PubMed, EMBASE, Scopus, and CINAHL, using keywords including "neuro optometry," "rehabilitation" or a related term, and "oculomotor problem" or "neurological problem" or a related term. Duplicates were eliminated through Mendeley software, and the quality of the selected studies was evaluated using JBI's critical appraisal tools. Two authors independently reviewed six full-text articles. Relevant data were extracted to Microsoft Excel, and a third author reviewed it. Any uncertainties were resolved through consultation with the last author. Selected studies included adults who had oculomotor problems resulted either from traumatic brain injury/stroke/cerebrovascular accidents and managed with various rehabilitative therapies. Office-based, home-based, or combination therapies with duration ranging from 8 to 12 weeks with the frequency of 2-5 sessions/week were found effective in managing oculomotor problems in adults. However, there is a need for more clinical studies with a larger sample size in this regard.

神经视力康复在影响眼睛的神经和发育疾病方面具有广泛的潜在康复应用。但支持其有效性的证据还很匮乏,尤其是在成人中。为了解决这一问题,我们系统地查阅了 2000 年 1 月至 2022 年 6 月间发表的英文文献,这些文献来自 PubMed、EMBASE、Scopus 和 CINAHL 等搜索引擎,使用的关键词包括 "神经视光学"、"康复 "或相关术语,以及 "眼球运动问题 "或 "神经问题 "或相关术语。通过 Mendeley 软件剔除了重复内容,并使用 JBI 的关键评估工具对所选研究的质量进行了评估。两位作者独立审阅了六篇全文。相关数据被提取到 Microsoft Excel 中,并由第三位作者进行审核。如有任何不确定之处,将与最后一位作者协商解决。所选研究纳入了因脑外伤/中风/脑血管意外导致眼部运动障碍并接受各种康复治疗的成年人。研究发现,办公室疗法、家庭疗法或综合疗法(持续时间为 8 至 12 周,频率为 2-5 次/周)对治疗成人的眼球运动问题有效。不过,在这方面还需要更多样本量更大的临床研究。
{"title":"Impact of neuro-optometric rehabilitation on adult oculomotor challenges - A systematic review.","authors":"Judy Jose, Bincy M George, Sulatha V Bhandary, Dushyanth Babu Jasti","doi":"10.4103/ojo.ojo_60_24","DOIUrl":"10.4103/ojo.ojo_60_24","url":null,"abstract":"<p><p>Neuro-optometric rehabilitation has a broad range of potential rehabilitative applications in neurological and developmental conditions affecting the eye. There is a dearth of evidence supporting its effectiveness, especially in adults. To address this issue, we systematically reviewed literature published in English between January 2000 and June 2022, obtained from search engines such as PubMed, EMBASE, Scopus, and CINAHL, using keywords including \"neuro optometry,\" \"rehabilitation\" or a related term, and \"oculomotor problem\" or \"neurological problem\" or a related term. Duplicates were eliminated through Mendeley software, and the quality of the selected studies was evaluated using JBI's critical appraisal tools. Two authors independently reviewed six full-text articles. Relevant data were extracted to Microsoft Excel, and a third author reviewed it. Any uncertainties were resolved through consultation with the last author. Selected studies included adults who had oculomotor problems resulted either from traumatic brain injury/stroke/cerebrovascular accidents and managed with various rehabilitative therapies. Office-based, home-based, or combination therapies with duration ranging from 8 to 12 weeks with the frequency of 2-5 sessions/week were found effective in managing oculomotor problems in adults. However, there is a need for more clinical studies with a larger sample size in this regard.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 3","pages":"320-324"},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620314/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142801888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Managing surgical aphakia and posterior capsular rupture with suture-assisted intraocular lens implantation. 缝线辅助人工晶状体植入术治疗手术性无晶状体及后囊膜破裂。
Q3 Medicine Pub Date : 2024-10-24 eCollection Date: 2024-09-01 DOI: 10.4103/ojo.ojo_239_23
Mukesh Kumar, Neha Chandak

Objective: This study aims to describe a novel technique for implanting an intraocular lens (IOL) in the sulcus using a 10-0 nylon suture in cases of intraoperative posterior capsular rupture (PCR) with inadequate capsular support, anterior capsular extension during continuous curvilinear capsulorrhexis extending to the posterior capsule, or posttraumatic cataract.

Methods: The study included 52 patients who underwent surgery at our hospital, during which an IOL was implanted with the assistance of a 10-0 nylon suture. All patients completed a 1-year follow-up period.

Results: In 48 of the 52 patients, the IOL remained stable. However, in two patients, the IOL dropped into the vitreous cavity approximately 1-month postsurgery. These two individuals required IOL explantation, pars plana vitrectomy, and secondary IOL (SFIOL) implantation.

Conclusion: Implanting an IOL in cases involving intraoperative PCR with inadequate capsular support, anterior capsular extension to the posterior capsule during continuous curvilinear capsulorrhexis, or posttraumatic cataract can be challenging. The technique of IOL implantation with the assistance of a 10-0 nylon suture, as described in this study, offers a straightforward and safe approach. In addition, it can help alleviate the financial and psychological trauma associated with a second surgery for both the patient and the surgeon.

目的:本研究旨在描述一种采用10-0尼龙缝线将人工晶状体(IOL)植入沟内的新技术,用于治疗术中后囊膜破裂(PCR)而囊膜支撑不足、前囊持续弯曲破裂延伸至后囊膜或外伤性白内障的病例。方法:本研究纳入52例在我院行手术的患者,手术期间采用10-0尼龙缝线植入人工晶状体。所有患者均完成了1年的随访。结果:52例患者中48例人工晶状体保持稳定。然而,在2例患者中,人工晶状体在术后1个月左右落入玻璃体腔。这两例患者需要人工晶状体植入术、玻璃体切除和二次人工晶状体植入术。结论:人工晶状体植入术中存在囊膜支撑不足、囊膜连续弯曲撕裂或外伤性白内障时前囊向后囊延伸等情况,人工晶状体植入术具有一定的挑战性。如本研究所述,人工晶状体植入技术在10-0尼龙缝线的帮助下,提供了一种简单而安全的方法。此外,它还可以帮助减轻患者和外科医生因第二次手术而带来的经济和心理创伤。
{"title":"Managing surgical aphakia and posterior capsular rupture with suture-assisted intraocular lens implantation.","authors":"Mukesh Kumar, Neha Chandak","doi":"10.4103/ojo.ojo_239_23","DOIUrl":"10.4103/ojo.ojo_239_23","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to describe a novel technique for implanting an intraocular lens (IOL) in the sulcus using a 10-0 nylon suture in cases of intraoperative posterior capsular rupture (PCR) with inadequate capsular support, anterior capsular extension during continuous curvilinear capsulorrhexis extending to the posterior capsule, or posttraumatic cataract.</p><p><strong>Methods: </strong>The study included 52 patients who underwent surgery at our hospital, during which an IOL was implanted with the assistance of a 10-0 nylon suture. All patients completed a 1-year follow-up period.</p><p><strong>Results: </strong>In 48 of the 52 patients, the IOL remained stable. However, in two patients, the IOL dropped into the vitreous cavity approximately 1-month postsurgery. These two individuals required IOL explantation, pars plana vitrectomy, and secondary IOL (SFIOL) implantation.</p><p><strong>Conclusion: </strong>Implanting an IOL in cases involving intraoperative PCR with inadequate capsular support, anterior capsular extension to the posterior capsule during continuous curvilinear capsulorrhexis, or posttraumatic cataract can be challenging. The technique of IOL implantation with the assistance of a 10-0 nylon suture, as described in this study, offers a straightforward and safe approach. In addition, it can help alleviate the financial and psychological trauma associated with a second surgery for both the patient and the surgeon.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 3","pages":"334-336"},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620301/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142801899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Teprotumumab versus intravenous methylprednisolone in thyroid eye disease: A systematic review. Teprotumumab与静脉注射甲基强的松龙治疗甲状腺眼病:一项系统综述
Q3 Medicine Pub Date : 2024-10-24 eCollection Date: 2024-09-01 DOI: 10.4103/ojo.ojo_308_23
Faizan Mehmood, Syed Ali Raza Rizvi, Sarah Alam, Benazir Ansari

Thyroid eye disease (TED), also known as thyroid-associated ophthalmopathy, is an autoimmune disorder caused due to a complex interplay between autoantigens including the thyroid-stimulating hormone receptor and the insulin-like growth factor-I receptor. TED is characterized by progressive proptosis or diplopia. This systematic review aimed to compare the efficacy of the newer monoclonal antibody - teprotumumab and intravenous methylprednisolone (IVMP) in TED patients. We performed a systematic review of previously published studies from 2013 to June 2023. A total of 329 articles were screened; among them, 111 non-duplicate publications were identified. After the screening of titles and abstracts, 156 publications were excluded; then, another 47 published papers were excluded after the full-text screening. The remaining 15 eligible studies were included in this systematic review. The majority of studies used either teprotumumab alone or in combination with others. Among 15 studies, eight studies used teprotumumab in TED patients, whereas remaining 7 studies used a standard treatment regimen. This systematic review provides an overview of the existing treatment options using monoclonal antibody - teprotumumab and IVMP in TED patients. The overall assessment provides a finding that antibody - teprotumumab is is a good choice compared to conventional IVMP for providing better outcomes in patients with TED.

甲状腺眼病(TED),也被称为甲状腺相关性眼病,是一种自身免疫性疾病,由自身抗原(包括促甲状腺激素受体和胰岛素样生长因子- 1受体)之间复杂的相互作用引起。TED以进行性突出或复视为特征。本系统综述旨在比较较新的单克隆抗体- teprotumumab和静脉注射甲基强的松龙(IVMP)在TED患者中的疗效。我们对2013年至2023年6月期间发表的研究进行了系统回顾。共筛选329篇文章;其中确定了111份非重复出版物。经过题目和摘要筛选,156份出版物被排除在外;然后,在全文筛选后,另外47篇已发表的论文被排除在外。其余15项符合条件的研究纳入本系统评价。大多数研究要么单独使用teprotumumab,要么与其他药物联合使用。在15项研究中,8项研究在TED患者中使用teprotumumab,而其余7项研究使用标准治疗方案。本系统综述概述了目前使用单克隆抗体- teprotumumab和IVMP治疗TED患者的治疗方案。总体评估发现,与传统的IVMP相比,抗体- teprotumumab是一个很好的选择,可以为TED患者提供更好的预后。
{"title":"Teprotumumab versus intravenous methylprednisolone in thyroid eye disease: A systematic review.","authors":"Faizan Mehmood, Syed Ali Raza Rizvi, Sarah Alam, Benazir Ansari","doi":"10.4103/ojo.ojo_308_23","DOIUrl":"10.4103/ojo.ojo_308_23","url":null,"abstract":"<p><p>Thyroid eye disease (TED), also known as thyroid-associated ophthalmopathy, is an autoimmune disorder caused due to a complex interplay between autoantigens including the thyroid-stimulating hormone receptor and the insulin-like growth factor-I receptor. TED is characterized by progressive proptosis or diplopia. This systematic review aimed to compare the efficacy of the newer monoclonal antibody - teprotumumab and intravenous methylprednisolone (IVMP) in TED patients. We performed a systematic review of previously published studies from 2013 to June 2023. A total of 329 articles were screened; among them, 111 non-duplicate publications were identified. After the screening of titles and abstracts, 156 publications were excluded; then, another 47 published papers were excluded after the full-text screening. The remaining 15 eligible studies were included in this systematic review. The majority of studies used either teprotumumab alone or in combination with others. Among 15 studies, eight studies used teprotumumab in TED patients, whereas remaining 7 studies used a standard treatment regimen. This systematic review provides an overview of the existing treatment options using monoclonal antibody - teprotumumab and IVMP in TED patients. The overall assessment provides a finding that antibody - teprotumumab is is a good choice compared to conventional IVMP for providing better outcomes in patients with TED.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 3","pages":"313-319"},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620316/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142801828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Oman Journal of Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1